107 related articles for article (PubMed ID: 10397549)
1. Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES.
Rusconi S; Merrill DP; La Seta-Catamancio S; Citterio P; Offord RE; Hirsch MS
AIDS; 1999 Jun; 13(9):1144-5. PubMed ID: 10397549
[No Abstract] [Full Text] [Related]
2. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
[TBL] [Abstract][Full Text] [Related]
3. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.
Hartley O; Gaertner H; Wilken J; Thompson D; Fish R; Ramos A; Pastore C; Dufour B; Cerini F; Melotti A; Heveker N; Picard L; Alizon M; Mosier D; Kent S; Offord R
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16460-5. PubMed ID: 15545608
[TBL] [Abstract][Full Text] [Related]
4. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
[TBL] [Abstract][Full Text] [Related]
6. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
[TBL] [Abstract][Full Text] [Related]
7. Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation.
Rusconi S; La Seta-Catamancio S; Kurtagic S; Galazzi M; Arienti D; Trabattoni D; Wilken J; Thompson DA; Offord RE; Galli M; Clerici M
AIDS Res Hum Retroviruses; 1999 Jul; 15(10):861-7. PubMed ID: 10408722
[TBL] [Abstract][Full Text] [Related]
8. Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.
Rusconi S; La Seta Catamancio S; Citterio P; Bulgheroni E; Croce F; Herrmann SH; Offord RE; Galli M; Hirsch MS
J Virol; 2000 Oct; 74(19):9328-32. PubMed ID: 10982382
[TBL] [Abstract][Full Text] [Related]
9. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.
Kawamura T; Cohen SS; Borris DL; Aquilino EA; Glushakova S; Margolis LB; Orenstein JM; Offord RE; Neurath AR; Blauvelt A
J Exp Med; 2000 Nov; 192(10):1491-500. PubMed ID: 11085750
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913
[TBL] [Abstract][Full Text] [Related]
11. Engineering chemokines to develop optimized HIV inhibitors.
Hartley O; Offord RE
Curr Protein Pept Sci; 2005 Jun; 6(3):207-19. PubMed ID: 15974948
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.
Secchi M; Longhi R; Vassena L; Sironi F; Grzesiek S; Lusso P; Vangelista L
Chem Biol; 2012 Dec; 19(12):1579-88. PubMed ID: 23261601
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.
Toossi Z; Mayanja-Kizza H; Baseke J; Peters P; Wu M; Abraha A; Aung H; Okwera A; Hirsch C; Arts E
Clin Exp Immunol; 2005 Nov; 142(2):327-32. PubMed ID: 16232220
[TBL] [Abstract][Full Text] [Related]
14. Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells.
Si Q; Kim MO; Zhao ML; Landau NR; Goldstein H; Lee S
Virology; 2002 Sep; 301(2):342-53. PubMed ID: 12359436
[TBL] [Abstract][Full Text] [Related]
15. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
16. Macrophages--promise and peril.
TreatmentUpdate; 1998 Dec; 10(10):4-5. PubMed ID: 11366018
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of primary R5 HTV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors.
Koning FA; Koevoets C; van der Vorst TJ; Schuitemaker H
Antivir Ther; 2005; 10(2):231-7. PubMed ID: 15865217
[TBL] [Abstract][Full Text] [Related]
19. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
20. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction.
Kinter A; Catanzaro A; Monaco J; Ruiz M; Justement J; Moir S; Arthos J; Oliva A; Ehler L; Mizell S; Jackson R; Ostrowski M; Hoxie J; Offord R; Fauci AS
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11880-5. PubMed ID: 9751759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
